We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: RINVOQ

Australian Public Assessment Report

AusPAR

AusPAR: Rinvoq [PDF, 6.09 MB]

AusPAR: Rinvoq [Word, 16.28 MB]

AusPAR Attachment 1: Product Information for Rinvoq [PDF, 899.11 KB]

AusPAR Attachment 1: Product Information for Rinvoq [Word, 457.81 KB]

Device/Product Name

Rinvoq

Active ingredients

Upadacitinib

AusPAR Date

6 March 2023

Published

16 March 2023

Submission Number

PM-2020-04791-1-1

Submission Type

Extension of indications and major variation (new strength)

Decision

Approved